By Topic

Neural System for in silico Drug-Drug Interaction Screening

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

3 Author(s)
Polak, S. ; Dept. of Pharmacoepidemiology & Pharmacoeconomics, Jagiellonian Univ., Cracow ; Brandys, J. ; Mendyk, A.

Drug usage is always associated with risk drugs interactions are considered to be one of the potential sources of undesirable action of drugs. Such a situation enforced U.S. Food and Drug Administration (FDA) as well as European Medicines Agency (EMEA) to issue a guidance for industry and researchers for in vivo and in vitro drug interactions studies. The authors proposed neural networks based in silico system for potential drug-drug interactions screening with use of simple physico-chemical data describing each chemical substance particle. Initial results where 77% of classification rate in generalization test was found suggest that computational intelligence based systems could be effective in this area

Published in:

Computational Intelligence for Modelling, Control and Automation, 2005 and International Conference on Intelligent Agents, Web Technologies and Internet Commerce, International Conference on  (Volume:2 )

Date of Conference:

28-30 Nov. 2005